GREENHEART GP Interim 2026: Net Loss Contracts to HK$11.72 Million as NZ Asset Sale Strengthens Balance Sheet

Bulletin Express
09/16

Greenheart Group Limited (“GREENHEART GP”) reported a sharply narrower net loss of HK$11.72 million for the six months ended 30 June 2026, an 88.0% improvement from the HK$97.60 million deficit a year earlier. The turnaround was driven by a HK$26.75 million gain on the disposal of most of the Mangakahia and Ormond Valley forests in New Zealand and the absence of losses from the previously divested Suriname division.

Revenue from continuing operations (New Zealand forestry and management services) declined 7.8% year-on-year to HK$19.03 million as radiata pine export volumes and prices softened. Nonetheless, gross profit rose 11.1% to HK$2.15 million, lifting gross margin to 11.3% (1H 2025: 9.4%) on higher-margin forest management services.

EBITDA from continuing operations dropped to HK$0.74 million (1H 2025: HK$11.15 million) after a HK$9.11 million fair-value loss on plantation assets. Administrative expenses rose 57.8% to HK$24.92 million, reflecting post-harvest cleaning costs and a one-off staff bonus.

The NZ$133.47 million (HK$626.82 million) asset sale, completed on 30 January 2026, significantly boosted liquidity. Cash and bank balances jumped to HK$520.12 million from HK$39.85 million at year-end 2025, while bank borrowings were fully repaid. Total debt now consists mainly of shareholder loans, reducing the gearing ratio to 76.9% (31 December 2025: 81.4%).

Net assets stood at HK$145.50 million versus HK$185.35 million at year-end, after the HK$27.83 million special dividend paid in March 2026. No interim dividend was declared.

Looking forward, management expects elevated shipping and operating costs to constrain margins but believes the strengthened balance sheet positions the group to pursue mature cutting-right acquisitions across Asia-Pacific under a disciplined capital-allocation framework. Post-period, an intra-group loan default event between subsidiaries is under review; no external creditor exposure was disclosed.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10